Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Pafolacianine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Lung Neoplasms 3 Stomach Neoplasms 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Appendiceal Neoplasms 1

Interventions

Ifosfamide 27 Methotrexate 25 Doxorubicin 22 Cyclophosphamide 20 Cisplatin 19 Filgrastim 15 Etoposide 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Specimen Handling 9 Granulocyte Colony-Stimulating Factor 8 fludarabine 7 Zoledronic Acid 7 X-Rays 7 Sirolimus 7 Nivolumab 7 Neoadjuvant Therapy 7 Irinotecan 7 Drug Therapy 7 Docetaxel 7 Carboplatin 7 Biopsy 7 mifamurtide 6 apatinib 6 Phantoms, Imaging 6 Mesna 6 cabozantinib 5 Vincristine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06235125 2024-08-22

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡